The role of E-cadherin as a tumor suppressor has been well established by the frequently observed loss of E-cadherin in a variety of cancers as well as the results of in vivo and in vitro analyses highlighting the role of E-cadherin as an inhibitor of invasive cancer 36–39. This evidence concerns the gene CDH1 and cancer.